Lexeo Therapeutics, Inc. (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

6.53

-0.38 (-5.50%)

At close: Apr 20, 2026, 4:00 PM EDT

6.54

+0.01 (0.12%)

Pre-market: Apr 21, 2026, 4:00 AM EDT

Lexeo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	63	35.01	121.47	77.34	135.86
Short-Term Investments	118.77	86.5	-	-	-
Cash & Short-Term Investments	181.77	121.52	121.47	77.34	135.86
Cash Growth	49.58%	0.04%	57.06%	-43.08%	362.53%
Other Current Assets	6.63	4.6	2.83	2.71	0.82
Total Current Assets	188.39	126.12	124.29	80.05	136.68
Net Property, Plant & Equipment	8.86	10.56	12.26	13.78	0.17
Long-Term Investments	68.19	7.01	-	-	-
Other Long-Term Assets	3.25	3.25	3.25	3.25	0
Total Assets	268.69	146.94	139.81	97.08	136.86
Accounts Payable	4.86	6.42	3.79	2.68	3.06
Accrued Expenses	9.28	13.76	10.84	8.33	3.81
Current Portion of Leases	2.68	2.67	2.61	2.83	-
Unearned Revenue	-	-	-	-	0.05
Other Current Liabilities	-	-	-	0.51	0.53
Total Current Liabilities	16.81	22.85	17.24	14.35	7.45
Long-Term Leases	5.21	7.25	9.03	10.65	-
Total Long-Term Liabilities	5.21	7.25	9.03	10.65	-
Total Liabilities	22.02	30.1	26.27	25	7.45
Common Stock	0.01	0	0	-	-
Treasury Stock	-0.02	-0.02	-	-	-
Additional Paid-in Capital	626.63	397.13	295.37	2.49	0.57
Accumulated Other Comprehensive Income	0.19	-0.1	-	-	-
Retained Earnings	-380.13	-280.17	-181.84	-115.45	-56.17
Total Common Shareholders' Equity	246.67	116.84	113.54	-112.95	-55.6
Minority Interest	-	-	-	185.03	185.01
Shareholders' Equity	246.67	116.84	113.54	72.08	129.41
Total Liabilities & Equity	268.69	146.94	139.81	97.08	136.86
Total Debt	7.89	9.92	11.64	13.48	0
Net Cash (Debt)	173.88	111.59	109.83	63.85	135.86
Net Cash Growth	55.82%	1.61%	72.00%	-53.00%	362.53%
Net Cash Per Share	3.24	3.51	20.51	39.16	87.50
Book Value	246.67	116.84	113.54	-112.95	-55.6
Book Value Per Share	4.60	3.68	21.20	-69.28	-35.81
Tangible Book Value	246.67	116.84	113.54	-112.95	-55.6
Tangible Book Value Per Share	4.60	3.68	21.20	-69.28	-35.81

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q